ReviewWorld journal of orthopedics2025
Therapeutic potential of traditional Chinese medicine for inflammatory bone diseases: Elucidating molecular mechanisms and insights.
Review in World journal of orthopedics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- OptiSyn: an interpretable, multi-omics-driven graph convolutional network framework for synergy-oriented drug combination design in disease treatment.Chinese medicine · 2026Article
- The recent progression of extracellular vesicles application in osteoporosis.Frontiers in pharmacology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Inflammatory bone diseases constitute a category of chronic inflammatory disorders, with the primary pathological characteristic being the impact of chronic inflammation on bone metabolism and remodeling. It leads to pain, spinal joint deformities, and functional impairments. Common clinical types of inflammatory bone diseases include rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis. However, there is a paucity of effective clinical treatments for inflammatory bone diseases, and pharmacological interventions are frequently associated with intolerable side effects. Traditional Chinese medicine (TCM) has a long-standing history and proven efficacy in managing inflammatory bone diseases. In recent years, an increasing number of studies have highlighted the potential of TCM in this context. This article systematically evaluates the application of TCM in treating inflammatory bone diseases, emphasizing the underlying molecular mechanisms of its anti-inflammatory effects. By elucidating the specific targets of TCM in the treatment of rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis, we aim to provide novel insights into the further exploration of TCM's role in clinical application for inflammatory bone diseases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.